Skin Rash Should Be a Huge Red Flag for LVAD Recipients, Group Says New phenomenon suggests perils of not performing biopsy in time Jul 07, 2021
Physician Organizations Challenge PA Name Change The AMA and AOA release statements against the rebrand Jun 09, 2021
Unhealthy Quest for Lighter Skin Fuels Bleaching Epidemic Breaking the centuries-old cycle of myths about skin color May 25, 2021
Rituximab Tops Mycophenolate Mofetil for Pemphigus Vulgaris Sustained complete response rate four times higher with anti-CD20 antibody May 19, 2021
Is This the Most TikTok'd COVID Vaccine Side Effect? Dermatologists say there's no issue: 'Happy filling, happy vaccinating' May 12, 2021
No Clarity for Role of Laser Therapy in Vulvar Lichen Sclerosus Mixed results from two small randomized clinical trials May 10, 2021
Another COVID-19 Side Effect: 'Zoom Dysmorphia' As people spend more time on camera, many of them like themselves less and less May 06, 2021
First Detailed Look at COVID Vaccine Skin Reactions Mostly mild, self-limiting reactions and no serious adverse reactions May 05, 2021
Rapid Improvement in Atopic Dermatitis With New JAK1 Inhibitor Plus: First-in-class drug shows promise in AD, BTK inhibitor active in pemphigus May 03, 2021
Topical JAK Inhibitor Shows Promise in Vitiligo Half of patients had 90% improvement after 2 years of treatment Apr 30, 2021
High Rate of Hyperhidrosis Relief With Topical Agent Benefit for 86% of patients treated with sofpironium bromide Apr 29, 2021
Rapid Improvement in Atopic Dermatitis With Topical JAK Inhibitor Disease activity index improved as early as week 1 with delgocitinib cream Apr 27, 2021
Significant Improvement in Hand Eczema With Pan-JAK Inhibitor Disease activity indicators reduced, no safety signals with gusacitinib versus placebo Apr 26, 2021
Big Win in Psoriasis for Dual IL-17A/17F Inhibitor Significant differences in clearance with bimekizumab vs secukinumab at all time points Apr 23, 2021
Nivolumab Alone Prevails in Resected Melanoma Adding ipilimumab in adjuvant setting failed to improve relapse-free survival Apr 11, 2021
For Enthesitis in Psoriatic Arthritis, Target IL-23 Targeted agent provides relief for many PsA patients Apr 08, 2021
COVID Triggers Novel Infectious Skin Condition in Teen Mild case led to unusual effects a week later Apr 07, 2021
JAK Inhibitor Promising in Psoriatic Arthritis Oral agent noninferior to adalimumab in joint symptoms Apr 01, 2021
Using the Skin Microbiome to Control Atopic Dermatitis Bacteria-based therapy shows promise in proof-of-concept trial Mar 01, 2021
Young Hidradenitis Suppurativa Patients See Lags in Care Diagnosis typically came years after disease onset; providers claim lack of knowledge on HS pain Feb 24, 2021
Want Data on Recently Approved Actinic Keratosis Drug? Here You Go Phase III trial now published in full for topical anti-proliferative treatment Feb 10, 2021
Monoclonal Antibody Highly Effective in Phase III Psoriasis Trial Beats ustekinumab, but main side effect was oral candidiasis Feb 05, 2021
Brain Tumor Risk Upped With Synthetic Progestogen Absolute risk still low, however, and product not currently approved in U.S. Feb 03, 2021
High Potassium No Threat With Spironolactone Despite guidelines, many still monitoring K levels in young women with acne, researchers find Jan 27, 2021
Masculinizing Hormone Therapy Tied to Acne in Transmen Acne also linked with depression and anxiety; Accutane may be treatment option Jan 20, 2021
Derm Symptoms Signal MIS-C in Kids Case series shows mucocutaneous findings in most children Dec 09, 2020
Renewed Concerns About Finasteride and Mental Health Database study links popular alopecia treatment with increased risks of suicidality, depression Nov 27, 2020
More Evidence for Ligelizumab in Chronic Hives Anti-IgE drug showed improved activity in omalizumab-treated patients with inadequate symptom control Nov 17, 2020
Watch for Suicidality in Men on Propecia Analysis found high number of psychological-related reports Nov 11, 2020
TYK2 Inhibition Promising in Psoriatic Arthritis Phase II study found significant benefits for two doses of novel agent Nov 10, 2020
Gut Bacteria for Psoriasis; Long-Term Hair Growth; COVID and STDs Selected presentations from the European Academy of Dermatology and Venereology virtual conference Nov 05, 2020
Nonsteroidal Topical, Nanodrug Active in Psoriasis Selected presentations from the European Academy of Dermatology and Venereology meeting Nov 04, 2020
Atopic Dermatitis: New Topical Agent, Durable Results With Orals Selected abstracts from the European Academy of Dermatology and Venereology Virtual Conference Nov 02, 2020
First-Ever Positive Phase III Trial in Epidermolysis Bullosa Faster wound healing with oleogel-S10, particularly in most common form of EB Nov 01, 2020
Add Skin Conditions to COVID-19 Long-Hauler Effects Persistence beyond 60 days in some cases, especially with pernio/chilblains Oct 30, 2020
Melanoma Survival Benefit Sustained at 5 Years With Adjuvant Combo Dabrafenib plus trametinib cut relapse risk in half Sep 02, 2020
Demographics Make a Difference in Common Skin Cancers Study looks at epidemiology of basal versus squamous cell carcinomas Aug 26, 2020
Calcineurin Blockers for Eczema: No Cancer Signal in Big Study "Clinicians can use this evidence to counsel and reassure patients" Aug 12, 2020